<DOC>
	<DOC>NCT02094547</DOC>
	<brief_summary>To compare the neurocognitive and immunological development in infants fed a new infant formula with functional specific nutrients to infants consuming a standard infant formula.</brief_summary>
	<brief_title>A Neurocognitive and Immunological Study of a New Formula for Healthy Infants</brief_title>
	<detailed_description />
	<criteria>Fullterm newborns (&gt;37 weeks and &lt;41 weeks gestation) Adequate birth weight for his gestational age (between 397 percentiles) Inclusion age: from 0 to 2 months (60 days) Maximum 30 days of exclusive breastfeeding From 30 days on, exclusive or &gt;70% infant formula Normal Apgar score: 710 Umbilical pH â‰¥ of 7.10 Availability to continue during the whole study period Informed consent signed ( parent/legal representative) Participating in other studies. Nervous system disorders (hydrocephalic, perinatal hypoxia, intraventricular hemorrhage, neonatal meningitis, septic shock, West Sd...). Gastrointestinal disorders (cow's milk protein allergy, lactose intolerance) Mother's disease history or during pregnancy: neurological and metabolic diseases, diabetes mellitus type 1, hypothyroidism, undernutrition, infections TORCH complex. Mothers receiving anxiolytic or antidepressant treatment during pregnancy or other potentially harmful drug treatments for infants' neurodevelopment. Infant currently participating in another clinical study Infant's family who in the investigators assessment cannot be expected to comply with the protocol.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>60 Days</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Infant Formula</keyword>
	<keyword>Cognition</keyword>
	<keyword>Neurodevelopment</keyword>
	<keyword>Immunity</keyword>
	<keyword>Microbiota</keyword>
</DOC>